Phase II clinical trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with previously untreated unresectable liver-only metastases from colorectal cancer.
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Oxaliplatin
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- Acronyms BOXER
- 01 Aug 2015 Status changed from active, no longer recruiting to completed as per European Clinical Trials Database record.
- 24 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.